As HIV prevention strategies continue to evolve, healthcare professionals across the globe face persistent knowledge gaps in evaluating and integrating the latest pre-exposure prophylaxis (PrEP) options, including long-acting injectable (LAI) agents. Many clinicians worldwide remain unfamiliar with the mechanisms of …
Men face unique behavioral health challenges that often go unrecognized due to stigma, cultural norms, and underreporting, leading to disparities in diagnosis and care. Across their lifespan, men’s mental health concerns frequently appear through externalizing behaviors, physical symptoms, or social …
Women experience a disproportionate burden of behavioral health conditions across their lifespan, yet unique clinical presentations often go underrecognized due to persistent stigma, gender disparities, and limited integration of mental health within women’s health care. From adolescence—when depression, anxiety, and …
Patients with chronic diseases frequently experience comorbid behavioral health disorders that complicate disease management, worsen outcomes, and increase health care utilization. Despite evidence linking psychiatric illnesses (e.g., depression, anxiety, bipolar disorder, schizophrenia) to poor adherence and higher mortality, behavioral health …
Long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) represents a major advancement in HIV prevention, offering new opportunities to support adherence and reduce transmission, yet its optimal use remains underrealized across global healthcare settings. Many HIV/infectious disease specialists, primary care clinicians, and …
Despite significant strides in HIV prevention, global incidence rates remain high, especially among underserved populations, due in part to persistent barriers in routine screening and access to pre-exposure prophylaxis (PrEP). Many healthcare professionals across the globe, including HIV and infectious …
Culturally respectful care starts at the very beginning of life, shaped by the rich lived experiences, traditions, and values that influence how children and families interact with the healthcare system. Every family brings unique circumstances, and clinicians and multidisciplinary teams …
Multiple sclerosis (MS) is a chronic, immune-mediated disease in which early, individualized disease-modifying therapy (DMT) can reduce disease activity, delay disability progression, and preserve quality of life. As therapeutic options expand—particularly multiple anti-CD20 therapies with different dosing schedules, administration routes, …
Retinal disease includes a wide array of conditions affecting the retina that, if not detected and treated early, can significantly impair quality of life, independence, and mobility while increasing the risk of accidental injury. These conditions also impose a substantial …